Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -51.78 | N/A |
| PEG Ratio (TTM) | -0.64 | N/A |
| P/S Ratio (TTM) | 0.41 | N/A |
| P/B Ratio (TTM) | 0.95 | N/A |
| P/FCF Ratio (TTM) | 30.14 | N/A |
| Price to 5YR AVG Earnings Ratio | 23.81 | N/A |
| Price to 5YR AVG FCF Ratio | 8.85 | N/A |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.76% | N/A |
| ROE (TTM) | -1.83% | N/A |
| Net Profit Margin (TTM) | -0.79% | N/A |
| ROIC 5YR AVG | 4.30% | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -12.30% | 97.17% | -6.64% |
| Revenue | -3.63% | 10.99% | 7.09% |
| Net Income | -10.40% | 100.93% | -4.17% |
| Cash Flow | 10.00% | 35.79% | 19.71% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.57 | N/A |
| Quick Ratio (TTM) | 0.37 | N/A |
| D/E Ratio (TTM) | 0.51 | N/A |
| Interest Coverage (TTM) | 0.41 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 1.44 | N/A |
| LTL to 5YR AVG FCF | 9.21 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.66% | N/A |